One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
Home » Companies » Roche Holding AG Company Profile

Roche Holding AG Company Profile

logo

Roche Holding AG

Pharmaceuticals

  • Type

    Public

  • Headquarters

    Switzerland

  • Founded

    1896

  • Key Management

    Mr.Severin Schwan(CEO)

  • Revenue

    ~69,940.6(2021)

  • Headcountz

    ~100,920(2021)

  • Website

    www.roche.com

Business Description

Roche Holding AG, a research-based healthcare firm, is its name. Fritz Hoffmann-La Roche was the founder of the company, which was established on October 1, 1896. It is located in Basel, Switzerland. It is divided into two parts: Diagnostics and Pharmaceuticals. The Pharmaceutical division encompasses business segments like Roche Pharmaceuticals and Chuga. The Diagnostic division covers the following areas: centralized and direct care, tissue diagnostics, molecular diagnostics, and diabetic care.

Key Financials

Revenue (US$ Mn):

 

  • US$ 69,941 Mn was Roche Holding AG’s annual revenue in 2021, an 8.41% increase from 2020 figures
  • Roche Holding AG indexed a 4.9% increase in annual revenues from 2019, amounting to US$ 64,515 Mn in 2020
  • Roche Holding AG generated total revenue of US$ 61,502 Mn in 2019
  • Annual revenue of US$ 57,150 Mn was indexed by Microsoft Corporation in 2018

 

Operating Income (US$ Mn):

 

  • US$ 19,283 Mn was the operating income generated by Roche Holding AG in 2021
  • Roche Holding AG’s operating income for 2020 was US$ 20,512 Mn, a 16.82% increase from 2019
  • From 2018’s operating incomes, Roche Holding AG registered an 18.46% increase in 2019, amounting to US$ 17,558 Mn
  • An operating income of US$ 14,822 Mn was generated in 2018 by Roche Holding AG

 

Net Income (US$ Mn):

 

  • Roche Holding AG’s net income for 2021 was US$ 15,863 Mn, a 0.32% increase from 2020
  • The net income generated by Roche Holding AG in 2020 was US$ 15,813 Mn
  • At a 27.93% increase, Roche Holding AG’s net income of US$ 13,505 Mn was indexed in 2019
  • Roche Holding AG generated a net income of US$ 10,556 Mn in 2018

 

Operating Margin %:

 

  • 28% was Roche Holding AG’s operating margin in 2021, a -13.52% decrease from 2020 figures
  • Roche Holding AG indexed an 11.58% increase in operating margins from 2019, amounting to 32% in 2020
  • Roche Holding AG generated an operating margin of 29% in 2019
  • An operating margin of 26% was indexed by Microsoft Corporation in 2018

 

Gross Margin %:

 

  • 23% was the gross margin generated by Roche Holding AG in 2021
  • Roche Holding AG’s gross margin for 2020 was 25%, an 11.87% increase from 2019
  • From 2018’s gross margins, Roche Holding AG registered a 19.02% increase in 2019, amounting to 22%
  • A gross margin of 18% was generated in 2018 by Roche Holding AG

 

SWOT Analysis

Strength:

Strong R&D Capabilities Help Roche in Keeping its Product Pipeline Robust

Roche is a leader in research and development (R&D). Roche has 29 R&D centers that are focused on developing innovative solutions, diagnostic tools and services, and new drugs based on changing market trends. It also holds numerous patents in foreign and domestic countries and collaborates with academia, biotech start-ups, and spin-offs of small and large corporations, universities, and government laboratories around the world. Two research organizations within Roche, pRED (Roche Pharma Research and Early Development), and red(Genentech Research and Early Development) are responsible for developing new treatments for diseases with high unmet medical needs.

Roche’s R&D programs are focused on the areas of ophthalmology, immunology, and oncology. The company spent CHF12,152 million on R&D in FY2020. This accounted for 3.9% of the company’s total revenue. The company’s innovation-based strategies allow it to keep up with industry changes and provide it with a ‘first mover” advantage by launching products before the competition. It also provides advanced products and services for its customers.

 

Get this premium content

The Premium data is Locked
Buy Now to Unlock Premium Data

Table of Content

  1. Business Description
  2. Key Financials
  3. SWOT Analysis
    1. Strength
      1. Strong R&D Capabilities Help Roche in Keeping its Product Pipeline Robust
      2. Market position established gives a competitive advantage over its peers
      3. Profitability
    2. Weaknesses
      1. Dependence on mature markets makes the company vulnerable to region-specific risks
    3. Opportunities
      1. Strategic Initiatives
      2. The US's aging population will drive demand for healthcare services
      3. Market share would be increased by acquisitions
    4. Threats
      1. Cost containment pressure in healthcare spending
      2. A time-consuming and costly development process could impact the commercial viability of potential products
      3. Problems with regulatory compliance could impact the company's operating expenses
    5. Key Developments
      1. Year 2021
      2. Year 2020
      3. Year 2019
      4. Year 2018
  • US $299
  • US $499
Buy Now
✖

Request For Company Data

We'll get back to you as quickly as possible

Primary Sidebar

  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

© 2025 Market.Us. All Rights Reserved.